Aytu Biopharma (AYTU) Current Assets (2011 - 2026)
Aytu Biopharma (AYTU) posted quarterly Current Assets of $67.3 million for Q1 2026, down 7.15% year-over-year from $72.5 million in Q1 2025, and down 11.69% quarter-over-quarter from $76.2 million in Q4 2025.
Aytu Biopharma (AYTU) Current Assets (2011 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has reported Current Assets for 16 consecutive years, with $67.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Assets fell 7.15% year-over-year to $67.3 million; the TTM figure through Mar 2026 stood at $67.3 million (down 7.15% YoY), while the FY2025 annual figure was $79.2 million, up 27.93% from the prior year.
- Current Assets declined to $67.3 million in Q1 2026 per AYTU's latest filing, from $76.2 million in the prior quarter.
- Across five years, Current Assets topped out at $81.1 million in Q3 2025 and bottomed at $59.9 million in Q2 2022.
- Historically, Current Assets has averaged $71.1 million across 5 years, with a median of $71.4 million in 2023.
- Annual changes were most pronounced in 2022 — Current Assets plunged 43.05% — and 2025, when it surged 33.54%.
- Aytu Biopharma's Current Assets stood at $70.6 million in 2022, then gained by 1.08% to $71.4 million in 2023, then fell by 11.65% to $63.1 million in 2024, then rose by 20.92% to $76.2 million in 2025, then slipped by 11.69% to $67.3 million in 2026.
- Business Quant data shows AYTU's Current Assets at $67.3 million in Q1 2026, $76.2 million in Q4 2025, and $81.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 3.22 Bn |
| 10 | Aytu Biopharma | 24.54 Mn | -2.17 Mn | 7.60 Mn | 67.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 67.33 Mn |
| Dec 31, 2025 | 76.24 Mn |
| Sep 30, 2025 | 81.11 Mn |
| Jun 30, 2025 | 79.18 Mn |
| Mar 31, 2025 | 72.51 Mn |
| Dec 31, 2024 | 63.05 Mn |
| Sep 30, 2024 | 60.74 Mn |
| Jun 30, 2024 | 61.89 Mn |
| Mar 31, 2024 | 71.13 Mn |
| Dec 31, 2023 | 71.37 Mn |
| Sep 30, 2023 | 70.60 Mn |
| Jun 30, 2023 | 72.83 Mn |
| Mar 31, 2023 | 78.47 Mn |
| Dec 31, 2022 | 70.61 Mn |
| Sep 30, 2022 | 74.42 Mn |
| Jun 30, 2022 | 59.93 Mn |
| Mar 31, 2022 | 77.95 Mn |
| Dec 31, 2021 | 87.54 Mn |
| Sep 30, 2021 | 89.04 Mn |
| Jun 30, 2021 | 105.23 Mn |